{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T05:51:59Z","timestamp":1761630719843},"reference-count":136,"publisher":"Informa UK Limited","issue":"4","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Future Microbiol."],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.2217\/fmb.14.122","type":"journal-article","created":{"date-parts":[[2015,4,13]],"date-time":"2015-04-13T11:22:38Z","timestamp":1428924158000},"page":"665-682","update-policy":"http:\/\/dx.doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":7,"title":["Adoptive T-cell Therapy in the Treatment of Viral and Opportunistic Fungal Infections"],"prefix":"10.1080","volume":"10","author":[{"given":"Nicasio","family":"Mancini","sequence":"first","affiliation":[{"name":"Laboratorio di Microbiologia e Virologia, Universit\u00e0 \u2018Vita-Salute\u2019 San Raffaele, DIBIT2, via Olgettina 58, 20132, Milan, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lara","family":"Marrone","sequence":"additional","affiliation":[{"name":"Laboratorio di Microbiologia e Virologia, Universit\u00e0 \u2018Vita-Salute\u2019 San Raffaele, DIBIT2, via Olgettina 58, 20132, Milan, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicola","family":"Clementi","sequence":"additional","affiliation":[{"name":"Laboratorio di Microbiologia e Virologia, Universit\u00e0 \u2018Vita-Salute\u2019 San Raffaele, DIBIT2, via Olgettina 58, 20132, Milan, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe A","family":"Sautto","sequence":"additional","affiliation":[{"name":"Laboratorio di Microbiologia e Virologia, Universit\u00e0 \u2018Vita-Salute\u2019 San Raffaele, DIBIT2, via Olgettina 58, 20132, Milan, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massimo","family":"Clementi","sequence":"additional","affiliation":[{"name":"Laboratorio di Microbiologia e Virologia, Universit\u00e0 \u2018Vita-Salute\u2019 San Raffaele, DIBIT2, via Olgettina 58, 20132, Milan, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Burioni","sequence":"additional","affiliation":[{"name":"Laboratorio di Microbiologia e Virologia, Universit\u00e0 \u2018Vita-Salute\u2019 San Raffaele, DIBIT2, via Olgettina 58, 20132, Milan, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2015,4,13]]},"reference":[{"key":"e_1_3_2_3_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.135.4.2895"},{"key":"e_1_3_2_4_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02303568"},{"key":"e_1_3_2_5_1","doi-asserted-by":"publisher","DOI":"10.4161\/onci.25962"},{"key":"e_1_3_2_6_1","doi-asserted-by":"publisher","DOI":"10.1517\/14712598.2014.860442"},{"key":"e_1_3_2_7_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-020711-074958"},{"key":"e_1_3_2_8_1","doi-asserted-by":"publisher","DOI":"10.1097\/PPO.0b013e31824d4465"},{"key":"e_1_3_2_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2007.09.006"},{"key":"e_1_3_2_10_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-07-232454"},{"key":"e_1_3_2_11_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0073648"},{"key":"e_1_3_2_12_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0073648"},{"key":"e_1_3_2_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2009.02.010"},{"key":"e_1_3_2_14_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm1001-1159"},{"key":"e_1_3_2_15_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm0602-631"},{"key":"e_1_3_2_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.beha.2008.02.007"},{"key":"e_1_3_2_17_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0901076"},{"key":"e_1_3_2_18_1","doi-asserted-by":"publisher","DOI":"10.1038\/mtna.2012.49"},{"key":"e_1_3_2_19_1","doi-asserted-by":"publisher","DOI":"10.1002\/0471142735.im0307s86"},{"key":"e_1_3_2_20_1","doi-asserted-by":"publisher","DOI":"10.1517\/14712590902849216"},{"key":"e_1_3_2_21_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-11-320226"},{"key":"e_1_3_2_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2796.2009.02085.x"},{"key":"e_1_3_2_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jim.2008.05.003"},{"key":"e_1_3_2_24_1","doi-asserted-by":"publisher","DOI":"10.1002\/eji.200838594"},{"key":"e_1_3_2_25_1","doi-asserted-by":"publisher","DOI":"10.1038\/ncponc1278"},{"key":"e_1_3_2_26_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11605-009-0839-1"},{"key":"e_1_3_2_27_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.163.1.507"},{"key":"e_1_3_2_28_1","doi-asserted-by":"publisher","DOI":"10.1089\/hum.2009.117"},{"key":"e_1_3_2_29_1","doi-asserted-by":"publisher","DOI":"10.1517\/14712598.7.6.893"},{"key":"e_1_3_2_30_1","doi-asserted-by":"publisher","DOI":"10.1038\/gt.2009.54"},{"issue":"69","key":"e_1_3_2_31_1","first-page":"e4235","article-title":"piggyBac transposon system modification of primary human T cells","author":"Saha S","year":"2012","unstructured":"Saha S , NakazawaY , HuyeLEet al. piggyBac transposon system modification of primary human T cells . J. Vis. Exp. ( 69 ), e4235 ( 2012 ).","journal-title":"J. Vis. Exp."},{"key":"e_1_3_2_32_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0028885"},{"key":"e_1_3_2_33_1","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.05039-11"},{"key":"e_1_3_2_34_1","doi-asserted-by":"publisher","DOI":"10.1089\/hum.2008.048"},{"key":"e_1_3_2_35_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11033-010-0053-y"},{"key":"e_1_3_2_36_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-06-1450"},{"key":"e_1_3_2_37_1","doi-asserted-by":"publisher","DOI":"10.1038\/mtna.2012.52"},{"key":"e_1_3_2_38_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0902055"},{"key":"e_1_3_2_39_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-09-1450"},{"key":"e_1_3_2_40_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2700"},{"key":"e_1_3_2_41_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20082487"},{"key":"e_1_3_2_42_1","doi-asserted-by":"publisher","DOI":"10.1038\/gt.2013.4"},{"issue":"6","key":"e_1_3_2_43_1","first-page":"2377","article-title":"Functional design of chimeric T-cell antigen receptors for adoptive immunotherapy of cancer: architecture and outcomes","volume":"32","author":"Shirasu N","year":"2012","unstructured":"Shirasu N , KurokiM . Functional design of chimeric T-cell antigen receptors for adoptive immunotherapy of cancer: architecture and outcomes . Anticancer Res.32 ( 6 ), 2377 \u2013 2383 ( 2012 ).","journal-title":"Anticancer Res."},{"key":"e_1_3_2_44_1","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-12-0548"},{"key":"e_1_3_2_45_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.86.24.10024"},{"key":"e_1_3_2_46_1","doi-asserted-by":"publisher","DOI":"10.1002\/jgm.2604"},{"key":"e_1_3_2_47_1","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201040608"},{"key":"e_1_3_2_48_1","doi-asserted-by":"publisher","DOI":"10.1002\/1521-4141(200212)32:12<3617::AID-IMMU3617>3.0.CO;2-M"},{"key":"e_1_3_2_49_1","doi-asserted-by":"publisher","DOI":"10.1038\/mt.2010.272"},{"key":"e_1_3_2_50_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2009.02672.x"},{"key":"e_1_3_2_51_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-08-239186"},{"key":"e_1_3_2_52_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2010.022947"},{"key":"e_1_3_2_53_1","unstructured":"ClinicalTrials.gov . Using multi-virus cytotoxic T-cells following T-Cell depleted allogeneic HPCT for prophylaxis against Epstein Barr Virus adenovirus and cytomegalovirus (ACE) . http:\/\/clinicaltrials.gov\/ct2\/show\/NCT01535885 ."},{"key":"e_1_3_2_54_1","unstructured":"ClinicalTrials.gov . Therapeutic effects of Epstein-Barr Virus immune T-lymphocytes derived from a normal HLA-compatible or partially-matched third-party donor in the treatment of EBV lymphoproliferative disorders and EBV-associated malignancies . http:\/\/clinicaltrials.gov\/ct2\/show\/NCT01498484 ."},{"key":"e_1_3_2_55_1","unstructured":"ClinicalTrials.gov . Cytomegalovirus \u2013 immunoprophylactic adoptive cellular therapy study (CMV-IMPACT) . http:\/\/clinicaltrials.gov\/ct2\/show\/NCT01077908 ."},{"key":"e_1_3_2_56_1","unstructured":"ClinicalTrials.gov . Injection of CD4 and CD8 + T Cells anti-cytomegalovirus (CMV) or anti-adenovirus (CTLantiCMV) . http:\/\/clinicaltrials.gov\/ct2\/show\/NCT01325636 ."},{"key":"e_1_3_2_57_1","unstructured":"ClinicalTrials.gov . Safety toxicity and MTD of one intravenous iv injection of donor CTLs specific for CMV and adenovirus (ACT-CAT) . http:\/\/clinicaltrials.gov\/ct2\/show\/NCT00880789 ."},{"key":"e_1_3_2_58_1","doi-asserted-by":"publisher","DOI":"10.1038\/mt.2012.138"},{"key":"e_1_3_2_59_1","doi-asserted-by":"publisher","DOI":"10.1038\/mt.2012.130"},{"key":"e_1_3_2_60_1","doi-asserted-by":"publisher","DOI":"10.1093\/clind\/13.Supplement_11.S966"},{"key":"e_1_3_2_61_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V99.11.3916"},{"key":"e_1_3_2_62_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)14634-X"},{"key":"e_1_3_2_63_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-08-448977"},{"key":"e_1_3_2_64_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.163.10.5512"},{"issue":"43","key":"e_1_3_2_65_1","first-page":"210","article-title":"Artificial antigen presenting cells that express prevalent HLA alleles: A step towards the broad application of antigen-specific adoptive cell therapies","volume":"8","author":"Hasan AN","year":"2009","unstructured":"Hasan AN , SelvakumarA , DoubrovinaE , RiviereI , SadelainMW , O\u2019reillyRJ . Artificial antigen presenting cells that express prevalent HLA alleles: A step towards the broad application of antigen-specific adoptive cell therapies . Discov. Med.8 ( 43 ), 210 \u2013 218 ( 2009 ).","journal-title":"Discov. Med."},{"key":"e_1_3_2_66_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20040613"},{"key":"e_1_3_2_67_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-01-262089"},{"key":"e_1_3_2_68_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0902233"},{"key":"e_1_3_2_69_1","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02117-09"},{"key":"e_1_3_2_70_1","first-page":"410","article-title":"Adoptive T-cell immunotherapy from third-party donors: characterization of donors and set up of a T-cell donor registry","volume":"3","author":"Eiz-Vesper B","year":"2012","unstructured":"Eiz-Vesper B , Maecker-KolhoffB , BlasczykR . Adoptive T-cell immunotherapy from third-party donors: characterization of donors and set up of a T-cell donor registry . Front. Immunol.3 , 410 ( 2012 ).","journal-title":"Front. Immunol."},{"key":"e_1_3_2_71_1","doi-asserted-by":"publisher","DOI":"10.3109\/14653249.2012.662769"},{"key":"e_1_3_2_72_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-006-6532-1"},{"key":"e_1_3_2_73_1","doi-asserted-by":"publisher","DOI":"10.1006\/clim.2000.4977"},{"key":"e_1_3_2_74_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-11-059139"},{"key":"e_1_3_2_75_1","doi-asserted-by":"publisher","DOI":"10.1097\/CJI.0b013e31817b9c6b"},{"key":"e_1_3_2_76_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-04-259291"},{"key":"e_1_3_2_77_1","doi-asserted-by":"publisher","DOI":"10.4161\/hv.24051"},{"key":"e_1_3_2_78_1","doi-asserted-by":"publisher","DOI":"10.3109\/14653249.2011.613932"},{"key":"e_1_3_2_79_1","doi-asserted-by":"publisher","DOI":"10.2174\/1874357901307010028"},{"key":"e_1_3_2_80_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2010.10.025"},{"key":"e_1_3_2_81_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2007.11.002"},{"key":"e_1_3_2_82_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2013.04.047"},{"key":"e_1_3_2_83_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1001018"},{"key":"e_1_3_2_84_1","doi-asserted-by":"publisher","DOI":"10.1038\/gt.2014.99"},{"key":"e_1_3_2_85_1","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2014-308316"},{"key":"e_1_3_2_86_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1002649"},{"key":"e_1_3_2_87_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.stem.2012.11.002"},{"key":"e_1_3_2_88_1","doi-asserted-by":"publisher","DOI":"10.1038\/mt.2012.284"},{"key":"e_1_3_2_89_1","doi-asserted-by":"publisher","DOI":"10.1038\/scientificamerican0312-54"},{"key":"e_1_3_2_90_1","doi-asserted-by":"publisher","DOI":"10.1006\/mthe.2002.0611"},{"key":"e_1_3_2_91_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcmd.2007.06.016"},{"key":"e_1_3_2_92_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3148.2010.01035.x"},{"key":"e_1_3_2_93_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-05-1775"},{"key":"e_1_3_2_94_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-12-325084"},{"key":"e_1_3_2_95_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcyt.2012.11.014"},{"key":"e_1_3_2_96_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1312789111"},{"key":"e_1_3_2_97_1","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.12006"},{"key":"e_1_3_2_98_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcmd.2007.07.002"},{"key":"e_1_3_2_99_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V95.7.2240"},{"key":"e_1_3_2_100_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11604-008-0291-2"},{"key":"e_1_3_2_101_1","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/509296"},{"key":"e_1_3_2_102_1","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.5.3.262"},{"key":"e_1_3_2_103_1","doi-asserted-by":"publisher","DOI":"10.1099\/vir.0.049759-0"},{"key":"e_1_3_2_104_1","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01281-09"},{"key":"e_1_3_2_105_1","doi-asserted-by":"publisher","DOI":"10.1155\/2010\/863985"},{"issue":"4","key":"e_1_3_2_106_1","first-page":"319","article-title":"Molecular cloning of the first human monoclonal antibodies neutralizing with high potency swine-origin influenza A pandemic virus (S-OIV)","volume":"32","author":"Burioni R","year":"2009","unstructured":"Burioni R , CanducciF , ManciniNet al. Molecular cloning of the first human monoclonal antibodies neutralizing with high potency swine-origin influenza A pandemic virus (S-OIV) . New Microbiol.32 ( 4 ), 319 \u2013 324 ( 2009 ).","journal-title":"New Microbiol."},{"key":"e_1_3_2_107_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0028001"},{"key":"e_1_3_2_108_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2011.07.013"},{"key":"e_1_3_2_109_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0034415"},{"issue":"3","key":"e_1_3_2_110_1","first-page":"289","article-title":"A phage display vector optimized for the generation of human antibody combinatorial libraries and the molecular cloning of monoclonal antibody fragments","volume":"35","author":"Solforosi L","year":"2012","unstructured":"Solforosi L , ManciniN , CanducciFet al. A phage display vector optimized for the generation of human antibody combinatorial libraries and the molecular cloning of monoclonal antibody fragments . New Microbiol.35 ( 3 ), 289 \u2013 294 ( 2012 ).","journal-title":"New Microbiol."},{"key":"e_1_3_2_111_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)61853-5"},{"key":"e_1_3_2_112_1","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/521231"},{"key":"e_1_3_2_113_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms13078273"},{"key":"e_1_3_2_114_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1535-6108(04)00058-3"},{"key":"e_1_3_2_115_1","doi-asserted-by":"publisher","DOI":"10.1099\/vir.0.81920-0"},{"key":"e_1_3_2_116_1","doi-asserted-by":"publisher","DOI":"10.4103\/0974-777X.52979"},{"key":"e_1_3_2_117_1","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2005.076646"},{"key":"e_1_3_2_118_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2014.04.005"},{"key":"e_1_3_2_119_1","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v19.i47.8940"},{"key":"e_1_3_2_120_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2008.03.008"},{"key":"e_1_3_2_121_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0008254"},{"key":"e_1_3_2_122_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2008.05.008"},{"key":"e_1_3_2_123_1","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01986-07"},{"key":"e_1_3_2_124_1","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/450963"},{"issue":"4","key":"e_1_3_2_125_1","first-page":"475","article-title":"Neutralization activity and kinetics of two broad-range human monoclonal IgG1 derived from recombinant Fab fragments and directed against Hepatitis C virus E2 glycoprotein","volume":"35","author":"Diotti RA","year":"2012","unstructured":"Diotti RA , SauttoGA , SolforosiL , ManciniN , ClementiM , BurioniR . Neutralization activity and kinetics of two broad-range human monoclonal IgG1 derived from recombinant Fab fragments and directed against Hepatitis C virus E2 glycoprotein . New Microbiol.35 ( 4 ), 475 \u2013 479 ( 2012 ).","journal-title":"New Microbiol."},{"issue":"4","key":"e_1_3_2_126_1","first-page":"387","article-title":"New therapeutic options for HCV infection in the monoclonal antibody era","volume":"35","author":"Sautto GA","year":"2012","unstructured":"Sautto GA , DiottiRA , ClementiM . New therapeutic options for HCV infection in the monoclonal antibody era . New Microbiol.35 ( 4 ), 387 \u2013 397 ( 2012 ).","journal-title":"New Microbiol."},{"key":"e_1_3_2_127_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2012.07.013"},{"key":"e_1_3_2_128_1","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/705013"},{"key":"e_1_3_2_129_1","doi-asserted-by":"publisher","DOI":"10.3390\/v4091731"},{"key":"e_1_3_2_130_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2014.08.011"},{"key":"e_1_3_2_131_1","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00114-09"},{"key":"e_1_3_2_132_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0003423"},{"key":"e_1_3_2_133_1","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2013.1.423"},{"key":"e_1_3_2_134_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e3283536a93"},{"key":"e_1_3_2_135_1","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2012.00409"},{"key":"e_1_3_2_136_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.48.11.4414-4421.2004"},{"key":"e_1_3_2_137_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-11-4036"},{"key":"e_1_3_2_138_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-11-3890"}],"container-title":["Future Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.2217\/fmb.14.122","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,23]],"date-time":"2024-06-23T06:38:35Z","timestamp":1719124715000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.2217\/fmb.14.122"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":136,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["10.2217\/fmb.14.122"],"URL":"https:\/\/doi.org\/10.2217\/fmb.14.122","relation":{},"ISSN":["1746-0913","1746-0921"],"issn-type":[{"value":"1746-0913","type":"print"},{"value":"1746-0921","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifmb20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifmb20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2015-04-13","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}